Molbio Diagnostics shares rally 9% as Jefferies initiates 'high conviction top pick' call for recently listed stock. Why is it bullish?
Indian markets moved higher in an ipo & listings development.
· Economic Times Markets, ET Stocks
Molbio Diagnostics shares jumped after Jefferies initiated coverage with a Buy rating and named it a high-conviction top pick. The brokerage set a Rs 1,600 target price, implying 27% upside from Tuesday’s close and nearly 98% above its Rs 807 IPO price. The stock had listed at a 21% premium at Rs 980.
The analysis
Listing activity is a read on risk appetite — a hot primary market usually means a confident secondary one.
Market context
- The immediate tone of coverage reads positive.
Related coverage
Reliance shares may be a cheaper way to buy Jio Platforms after its listing
Bharti Airtel's Sunil Bharti Mittal backs Jio's public listing, says ‘looking forward to a very successful IPO’
Vodafone Idea zooms 12% after FPO sees 6x subscription; focus shifts to allotment, listing
PSP Projects share gains 4% on launching Rs 244-crore QIP
Indus Towers gains 4% after CLSA upgrade to #39;buy#39; on Voda Idea FPO